Downloads background

Press and Media

The latest news and press resources

Press and Media
  • In the Press
  • Press Kit
Betakit

Drugbank Closes $9 Million

Now, with $9 million CAD in seed financing led by Montréal-based Brightspark Ventures, and supported by a group of strategic investors from the precision medicine and pharma spaces, DrugBank is ready to grow its team and expand its AI capabilities.

Amii

AI Week Brings Together the World AI Community

Four days of events will feature keynotes and talks from leaders in AI and machine learning. Amii (the Alberta Machine Intelligence Institute) has announced the program for AI Week, May 24-27 in Edmonton, Canada.

Taproot

Drugbank’s Culture is Helping Build Critical Infrastructure for Healthcare

The Edmonton-based company’s debut at 19th in the under 50 employees category closely follows its success in raising $9 million of seed funding, led by Brightspark Ventures, earlier this month.

Ctvnews

Yeg Startup Community Awards Hosted for First Time, Recognize RWI Synthetics

An Edmonton start-up company is getting recognition for its cutting edge technology that can help in emergency situations.

Globenewswire

DrugBank Expands Coverage To Seven New Regions, Grows Global Influence

DrugBank, the world's most complete and up-to-date pharmaceutical knowledge database, expands coverage to better serve global customers.

Cbc

Edmonton Startup’s Drug Database Used by Millions Worldwide

Now, with $9 million CAD in seed financing led by Montréal-based Brightspark Ventures, and supported by a group of strategic investors from the precision medicine and pharma spaces, DrugBank is ready to grow its team and expand its AI capabilities.

Acceleratefund

Accelerate Fund II Invests in Drugbank the World’s Largest Pharmaceutical Knowledge Base

Accelerate Fund II is excited to announce its investment in DrugBank, an Edmonton company that has developed a comprehensive, online knowledge base of essential information on drugs and drug targets.

Differentialventures

Announcing the Second Round of Covid-19 Grants!

On March 29th, our team announced a $500,000 pool of funds to be awarded in $10,000 - $25,000 grants to startups that are using data science, machine learning, and artificial intelligence to find solutions for the myriad challenges created by COVID-19.

Taproot

Drugbank Wins $125K Startup TNT Investment Summit

DrugBank, which offers “a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information,” won the $125,000 Startup TNT Investment Summit pitch competition last week.

A little bit about us

DrugBank is the world’s first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our expert team authors, verifies, and structures all of the latest biomedical information so that it can be used to its fullest potential.

A little bit more about us

DrugBank is the world’s first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our team of medical and scientific experts gather, author, verify, and structure all of the latest biomedical information into one knowledge platform. We make this platform easy to access through DrugBank Online (our free-to-use website), data downloads, or software integrations.

Our goal is to augment human intelligence so that all medical information is used to its fullest potential, because we want to ensure that everyone in the world has access to the best possible medical outcomes.

Brand Assets

Get our brand assets kit, including logos and usage guide to help determine when and how to utilize our brand.

Download Assets
Logo pink

Looking For Photos?

Download team and office photos and executive team headshots.

Download Photo Pack
Teamphotos

Our customers love us!

From our Clinical API to Drug Datasets, DrugBank has what you need